A detailed history of Gratus Capital LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Gratus Capital LLC holds 25,855 shares of BDX stock, worth $5.79 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
25,855
Previous 25,756 0.38%
Holding current value
$5.79 Million
Previous $6.37 Million 5.19%
% of portfolio
0.25%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$225.07 - $246.17 $22,281 - $24,370
99 Added 0.38%
25,855 $6.04 Million
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $28,947 - $30,718
124 Added 0.48%
25,756 $6.37 Million
Q4 2023

Feb 07, 2024

BUY
$232.24 - $267.23 $4.04 Million - $4.65 Million
17,396 Added 211.22%
25,632 $6.25 Million
Q3 2023

Oct 26, 2023

BUY
$254.9 - $283.59 $15,039 - $16,731
59 Added 0.72%
8,236 $2.13 Million
Q2 2023

Aug 02, 2023

SELL
$238.39 - $265.32 $11,204 - $12,470
-47 Reduced 0.57%
8,177 $2.16 Million
Q1 2023

Apr 19, 2023

SELL
$229.71 - $259.35 $90,735 - $102,443
-395 Reduced 4.58%
8,224 $2.04 Million
Q4 2022

Jan 27, 2023

SELL
$218.29 - $256.91 $21,392 - $25,177
-98 Reduced 1.12%
8,619 $0
Q3 2022

Nov 03, 2022

SELL
$51.03 - $264.23 $9,032 - $46,768
-177 Reduced 1.99%
8,717 $1.94 Million
Q1 2022

Apr 29, 2022

SELL
$243.64 - $270.48 $88,441 - $98,184
-363 Reduced 3.92%
8,894 $2.37 Million
Q4 2021

Jan 31, 2022

SELL
$230.08 - $250.94 $3,911 - $4,265
-17 Reduced 0.18%
9,257 $2.33 Million
Q3 2021

Nov 05, 2021

SELL
$232.72 - $256.47 $19,315 - $21,287
-83 Reduced 0.89%
9,274 $2.28 Million
Q2 2021

Aug 10, 2021

SELL
$232.65 - $254.58 $749,365 - $820,002
-3,221 Reduced 25.61%
9,357 $2.28 Million
Q1 2021

May 04, 2021

BUY
$232.09 - $256.88 $13,925 - $15,412
60 Added 0.48%
12,578 $3.06 Million
Q3 2020

Oct 30, 2020

SELL
$215.77 - $276.76 $81,129 - $104,061
-376 Reduced 2.92%
12,518 $2.91 Million
Q2 2020

Aug 11, 2020

SELL
$219.9 - $263.41 $2,858 - $3,424
-13 Reduced 0.1%
12,894 $3.09 Million
Q1 2020

May 01, 2020

SELL
$195.69 - $279.01 $28,179 - $40,177
-144 Reduced 1.1%
12,907 $2.97 Million
Q4 2019

Feb 07, 2020

SELL
$236.45 - $266.82 $6,147 - $6,937
-26 Reduced 0.2%
13,051 $3.55 Million
Q3 2019

Oct 30, 2019

SELL
$230.58 - $256.08 $88,773 - $98,590
-385 Reduced 2.86%
13,077 $3.31 Million
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $39,149 - $47,152
-190 Reduced 1.39%
13,462 $3.36 Million
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $28.7 Million - $36.2 Million
-140,400 Reduced 91.14%
13,652 $3.08 Million
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $28.7 Million - $36.2 Million
140,321 Added 1021.93%
154,052 $3.31 Million
Q3 2018

Nov 09, 2018

SELL
$233.07 - $256.0 $114,903 - $126,208
-493 Reduced 3.47%
13,731 $3.58 Million
Q2 2018

Aug 13, 2018

SELL
$208.1 - $233.85 $145,670 - $163,695
-700 Reduced 4.69%
14,224 $3.41 Million
Q1 2018

May 10, 2018

SELL
$205.46 - $240.27 $79,102 - $92,503
-385 Reduced 2.51%
14,924 $3.23 Million
Q4 2017

Feb 07, 2018

SELL
$189.0 - $222.64 $12,663 - $14,916
-67 Reduced 0.44%
15,309 $3.28 Million
Q3 2017

Nov 09, 2017

SELL
$186.89 - $198.9 $49,525 - $52,708
-265 Reduced 1.69%
15,376 $3.01 Million
Q2 2017

Aug 08, 2017

BUY
N/A
15,641
15,641 $3.05 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Gratus Capital LLC Portfolio

Follow Gratus Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.